Skip to main content
Caplight Logo









GrandOmics Biosciences

GrandOmics Biosciences

Private
BeijingHealthcare & Life Scienceshttps://www.grandomics.com/

Last Round

Series B

Jul 2, 2018

Total Funding Raised

$29.4M

Company Overview

GrandOmics Biosciences is a biotechnology company that provides third-generation sequencing services, bioinformatics analysis, and genomic solutions for human, animal, plant, and microbial research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

long-read sequencingthird-generation sequencingbioinformaticsgenome assemblygenomicsnext-gen sequencingstructural variationpathogen detectiongenetic disease analysisbioinformatics pipelineOxford NanoporePacBioNGSde novo assemblyprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GrandOmics Biosciences Comparables

Compare GrandOmics Biosciences with similar companies based on industry and business-model similarity.

GrandOmics Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wuhan Frasergen Bioinformatics Co., Ltd.
87%
Wuhan Benagen Technology Co., Ltd.
86%
Beijing Biomarker Technologies Co., Ltd.
83%

GrandOmics Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 2, 2018
Series ADec 5, 2016
AngelDec 1, 2015

GrandOmics Biosciences Investors

Notable investors and investment history

GrandOmics Biosciences investors
InvestorRounds
Zero2IPO Venture CapitalSeries A
Marathon Venture PartnersSeries B
MPCSeries B, Series A
SAIF PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2018

    $15M round led by Marathon Venture Partners.

GrandOmics Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GrandOmics Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GrandOmics Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range12
Year Founded2011
Last FundingJul 2, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?